Exceptions to the Prescription Drug List: Closed consultation
From: Health Canada
Current status: Closed
This consultation ran from July 28, 2022 to November 29, 2022.
We sought input from health care providers and other stakeholders on current exceptions to the Prescription Drug List, as part of regulatory modernization. We will use the information gathered from this consultation to inform updated health and safety rationales for exceptions to the Prescription Drug List.
Who was the focus of this consultation
We engaged with:
- healthcare professionals
- patients and caregivers
- health product industry
- government and regulatory partners
- other interested stakeholders
Key questions
To seek your feedback on whether some exceptions to the Prescription Drug List are still required and why we prepared:
- a consultation guide
- an online questionnaire
- a product list
We also wanted to know what impacts could result if these drugs were to be added to the Prescription Drug List.
Related links
Contact us
Exceptions to the Prescription Drug List
Health Products and Food Branch
policy_bureau_enquiries@hc-sc.gc.ca